AB
Alternative Names: AB - AROMICS; Influenza virus therapeutic - AROMICSLatest Information Update: 03 Oct 2023
At a glance
- Originator AROMICS
- Class Antivirals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Preclinical Influenza virus infections
Most Recent Events
- 20 Sep 2023 AB is available for licensing as of 20 Sep 2023. https://aromics.es/en/section/research
- 20 Sep 2023 Preclinical trials in Influenza virus infections in Spain (unspecified route) prior to September 2023 (AROMICS pipeline, September 2023)